Non-small Cell Lung Cancer (NSCLC), Stage IV

Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic

DrugDrug NameDrug Description
DB00441GemcitabineGemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. As with fluorouracil and other analogues of pyrimidines, the drug replaces one of the building blocks of nucleic acids, in this case cytidine, during DNA replication. The process arrests tumor growth, as new nucleosides cannot be attached to the "faulty" nucleoside, resulting in apoptosis (cellular "suicide"). Gemcitabine is used in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. It is being investigated for use in oesophageal cancer, and is used experimentally in lymphomas and various other tumor types.
DrugDrug NamePhaseStatusCount
DB06643Denosumab3Active Not Recruiting1
DB12349Dulanermin3Active Not Recruiting1